4D Molecular Therapeutics, Inc. (FDMT): Shares Outstanding

Annual figures by period end, from SEC filings.

57.61M
As of 2025-12-31
55.21M
As of 2026-06-30
+20.9%
3-year compound annual growth
+16.6%
5-year compound annual growth
2019-12-31: 5.18M2020-12-31: 26.68M2021-12-31: 32.22M2022-12-31: 32.63M2023-12-31: 43.08M2024-12-31: 45.79M2025-12-31: 57.61M57.61M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3157.61M+25.8%2026-03-18, Balance as of period end
2024-12-3145.79M+6.3%2026-03-18, Balance as of period end
2023-12-3143.08M+32.0%2025-02-28, Balance as of period end
2022-12-3132.63M+1.2%2024-02-29, Balance as of period end
2021-12-3132.22M+20.8%2023-03-15, Balance as of period end
2020-12-3126.68Mn/c2022-03-28, Balance as of period end
2019-12-315.18Mn/a2021-03-25, Balance as of period end